From left, Catherine Cochrane, Professor David Graham and Kathryn Thomson
Liverpool, UK - 22 March 2010: The University of Liverpool, in partnership with NHS Trusts, universities, patients and industry across Merseyside and Cheshire, is developing a new initiative to ensure research outcomes are adopted quickly for the benefit of patient care. The Health Innovation and Education Cluster (HIEC) will employ a team of outreach staff who will work with leading scientists and healthcare professionals to translate research outcomes and innovation into education and patient care. Based at the University of Liverpool, the Merseyside and Cheshire HIEC will focus on six key themes, including Drug Safety; Children's Health; Mental and Physical Health; Cancer; Infection and Public Health. As part of the Drug Safety programme, scientists will investigate how adverse drug reactions (ADRs) can be prevented. It is estimated that ADRs cost the NHS in the region of £750M per annum. The HIEC will offer all NHS staff involved in prescribing drugs, a new training module in 'safe prescribing'. Professor David Graham, Head of the University's Medical School and Director of the HIEC, said: "The HIEC will improve the education and training of the healthcare workforce and speed up the adoption of innovation and research in hospitals.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
